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Disease-Specific, Versus Standard, Nutritional Support for the
Treatment of Pressure Ulcers in Institutionalized Older Adults:
A Randomized Controlled Trial
Emanuele Cereda, MD, Anna Gini, MD,w Carlo Pedrolli, MD,z and Alfredo Vanotti, MDw
OBJECTIVES: To investigate whether a disease-specific
nutritional approach is more beneficial than a standard
dietary approach to the healing of pressure ulcers (PUs) in
institutionalized elderly patients.
DESIGN: Twelve-week follow-up randomized controlled
trial (RCT).
SETTING: Four long-term care facilities in the province of
Como, Italy.
PARTICIPANTS: Twenty-eight elderly subjects with Stage
II, III, and IV PUs of recent onset (o1-month history).
INTERVENTION: All 28 patients received 30 kcal/kg per
day nutritional support; of these, 15 received standard
nutrition (hospital diet or standard enteral formula; 16%
calories from protein), whereas 13 were administered a
disease-specific nutrition treatment consisting of the stan-
dard diet plus a 400-mL oral supplement or specific enteral
formula enriched with protein (20% of the total calories),
arginine, zinc, and vitamin C (Po.001 for all nutrients vs
control).
MEASUREMENTS: Ulcer healing was evaluated using the
Pressure Ulcer Scale for Healing (PUSH; 05 complete heal-
ing, 175 greatest severity) tool and area measurement
(mm2 and %).
RESULTS: The sampled groups were well matched for age,
sex, nutritional status, oral intake, type of feeding, and ul-
cer severity. After 12 weeks, both groups showed significant
improvement (Po.001). The treatment produced a higher
rate of healing, the PUSH score revealing a significant
difference at Week 12 (6.1  2.7 vs 3.3  2.4; Po.05)
and the reduction in ulcer surface area significantly higher
in the treated patients already by Week 8 ( 1,140.9 
669.2mm2 vs  571.7  391.3mm2; Po.05 and  57%
vs  33%; Po.02).
CONCLUSION: The rate of PU healing appears to accel-
erate when a nutrition formula enriched with protein, argi-
nine, zinc, and vitamin C is administered, making such a
formula preferable to a standardized one, but the present data
require further confirmation by high-quality RCTs conducted
on a larger scale. J Am Geriatr Soc 57:1395–1402, 2009.
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All over the world, the incidence and prevalence ofpressure ulcers (PUs) has reached significant propor-
tions in long-term geriatric wards, with 3% to 30%of those
admitted to institutions having PUs.1–3 The consequences of
this escalation in PUs are substantial and can be seen in the
significant association with morbidity, mortality, length of
‘‘hospital’’ stay, and overall health costs,2,4,5 but adherence
to comprehensive prevention protocols has been shown to
lead to a consistent reduction in ulcer incidence.1,2 Pre-
venting and treating PUs requires a complex interaction of
interventions. In this respect, although avoiding (removing/
redistributing) persistent pressure at bony sites is still the
most important measure,6 delivering adequate nutritional
care has now been recognized as being of additional ben-
efit.1–4,6–9 In fact, in frail elderly patients, PUs and malnu-
trition frequently coexist,10,11 and certain nutritional
factors, such as recent weight loss,12 impaired food intake,
and low protein dietary intake,11,13 appear to be associated
with PU development. In addition, recent meta-analyses
have clearly highlighted an association between enteral nu-
trition support, particularly with high protein content, and
significantly lower PU incidence.2,14 Unfortunately, partic-
ularly with regard to treatment, similar robust evidence
from randomized controlled trials (RCTs) is still lacking,
and no high-level nutritional recommendations have been
produced.14 The energy requirements of elderly patients
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with PUs and other comorbidities do not seem any greater
than those of risk-matched controls.15 In any case, adequate
energy should be delivered to cover requirements and to
promote new tissue synthesis. Preliminary experience sup-
ports the use of protein-enriched formulas in the healing of
PUs.16–18 Although earlier investigations into the healing
process failed to demonstrate any consistent benefit from
single-nutrient supplementation,10 the recent literature pro-
vides some evidence of potential benefits that could derive
from the concomitant supplementation of arginine, zinc,
and antioxidant vitamins.18,19 Accordingly, companies sell-
ing nutritional supplements are trying to achieve improve-
ments in the field by producing putative ‘‘disease specific’’
formulations and to clarify the mechanisms involved, but
until now, no high-quality trial has been designed to test the
efficacy of such formulations. The present study was un-
dertaken to evaluate the use of a disease-specific nutritional
treatment enriched in protein, arginine, zinc, and vitamin
C and to compare it with a standard protocol for improving
the rate of PU healing.
MATERIALS AND METHODS
A RCTwith a 12-week follow-up was performed, with data
collected over a 5-month period (November 2007–March
2008). Residents of long-term care aged 65 and older ad-
mitted to four different facilities of the province of Como
(Italy) were screened for PUs. Subjects were considered el-
igible if they had Stage II, III, or IV lesions as assessed ac-
cording to the revised (2007) National Pressure Ulcer
Advisory Panel staging system.20 Patients fed orally and
through feeding tubes were included. Exclusion criteria
were presence of acute illness (e.g, infection) or chronic
disease (e.g., diabetes mellitus, peripheral vascular disease,
autoimmune or neoplastic disorders) possibly affecting the
nutritional intervention and healing process, positive cul-
ture from PU swab sampling, use of immunosuppressive
therapies, development of the lesion more than 1 month
before evaluation, and lack of dietary adherence (o85%
of prescription). Informed consent was obtained from all
patients enrolled.
Allocation to the intervention groups was defined ac-
cording to a computer-generated randomization list.
This study was performed in adherence to the princi-
ples established by the Declaration of Helsinki, and the
ethics committees of the institutions involved gave final
approval.
Nutritional Interventions
All patients received nutritional support of at least 30 kcal/
kg per day regardless of feeding method; no modification
was made for patients who were already receiving more
than 30 kcal/kg per day before enrollment in the study.
Treatment Group
In participants who were fed orally, two bottles (400mL) of
a high-energy enriched formula (Cubitan, Nutricia, Milan,
Italy), which provided a total of 500 kcal, 34 g protein, 6 g
arginine, 500mg vitamin C, and 18mg zinc, were admin-
istered along with a standard hospital diet to reach the
estimated energy requirements.
In participants who were tube fed, 1,000mL of a high-
protein formula (20% energy from protein; Cubison, Nut-
ricia) enriched with arginine, zinc, and vitamin C (in
100mL: 100 kcal, 5.5 g protein, 0.85 g arginine, 38mg vi-
tamin C, and 2mg zinc) were infused together with appro-
priate volumes of an isocaloric standard formula (Nutrison;
16% energy from protein, in 100mL: 100 kcal, 4.0 g pro-
tein, 0 g arginine, 10mg vitamin C, and 1.2mg zinc) to
reach the energy requirements.
Control Group
In participants who were orally fed, the nutritional treat-
ment consisted of a standard hospital diet (16% energy
from protein) without any additional supplement. In sub-
jects who were tube fed, energy and the infusion of appro-
priate volumes of a standard formula satisfied protein
requirements (Nutrison).
PU Care
All patients received similar wound care according to stan-
dard protocols used in the wards. Local pressure to the
areas was avoided, or at least reduced, using a turning and
repositioning program, a dynamic air mattress on the bed,
and a gel cushion for when sitting out of bed. The same
professional nurse, who was blinded to the nutritional in-
terventions, always applied topical treatments, in accor-
dance with accepted guidelines;6 the treatment depended on
lesion depth and position, amount of exudate, type of tissue
in the wound base, and presence of infection. In this last
case, local antibiotic therapy was delivered according to
germ isolation and antibiogram results. Systemic therapy
was instituted only in the presence of bacteriemia or sepsis,
defined as fever (4381C) or hypothermia (o361C) and one
or more positive blood cultures for pathogenic organisms.
Nutritional and PU Assessments
Anthropometric and biochemical data were collected at the
beginning (baseline) and at the end (Week 12) of the study.
Weight, to the nearest 0.1 kg, was measured using the same
calibrated scale. For subjects who were bedridden, a chair
scale or a hoist provided with a weighing device was used.
Estimated height was derived to the nearest 0.5 cm from
knee height using anthropometric calipers according to
standard procedures,21 and body mass index (BMI) was
calculated. Any history of recent weight loss was obtained
retrospectively from the clinical register of the patients. A
biochemical examination, after 8 to 12 hours fasting, in-
cluded total blood count, liver function tests, urea, creati-
nine, electrolytes, total protein evaluation, albumin,
transferrin, glucose, total cholesterol, and serum zinc.
Nutrition-related risk of complications was graded using
the Geriatric Nutritional Risk Index, which is based on
the combined predictive value of albumin and low body
weight ([1.489  albumin, g/L]1[41.7  present/ideal body
weight]). This tool was recently introduced into clinical
practice because of its significant association with the occur-
rence of major outcomes, such as pressure ulcers, infection,
and death. Given the frequent difficulties associated with el-
derly patient participation in nutritional assessment, the fea-
sibility of such a tool has also been highlighted in different
settings, particularly in long-term care facilities.22,23
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Nutritional intake before and during the study was as-
sessed as follows. Types and amounts of infused formula
were collected from the clinical register of every patient
receiving enteral administration. In participants who were
orally fed, the same well-trained dietitian weighed and
recorded the amount of food delivered to and left by the
patients at three main meals (breakfast, lunch, dinner). In
this way, the average daily protein (g/d), vitamin C (mg/d),
arginine (g/d), and zinc (mg/d) intake was computed man-
ually using the Italian National Table of Food Composi-
tion.24 The analysis for the treatment group included the
nutritional supplement contribution. The mean of three
consecutive days was considered for the statistical analyses,
and throughout the study, a weekly assessment was made of
dietary compliance. Data were also normalized for patient
body weight (g or mg/kg per day).
The samewell-trained operator (AG), whowas blind to
the nutritional interventions performed PU assessments at
defined time points: baseline andWeeks 2, 4, 6, 8, and 12. In
patients with multiple lesions, the most severe lesion was
considered for the analysis. Changes (improvement or de-
terioration) in ulcer healing were monitored and described
using the Pressure Ulcer Scale for Healing (PUSH) tool.25
This tool assigns subscores according to surface area (length
 width), exudate amount, and tissue type in the ulcer bed.
Thus, a final total score categorizes lesion severity through a
scale ranging from 0 (completely healed) to 17 (greatest se-
verity). Finally, to avoid any possible bias in patient enroll-
ment, an assessment was made of the patients’ baseline risk
for PU development; this was computed using the Norton
Scale, one of the first-developed risk-assessment scales and
one that is still widely used because of its relative ease of use
and its accuracy, and compared with the specialist nurse’s
clinical judgment.26,27 The Norton Scale is made up of five
subscales that measure the functional capabilities (physical
condition, mental status, activity, mobility, and inconti-
nence) of the person at risk. Each subscale assigns a score of
1 to 4 points (1 for low level and 4 for highest level of func-
tioning), contributing to a total score ranging from 5 to 20.
Outcomes
The primary endpoint was PU healing, as described by
reduction in PUSH score and lesion area (mm2 and %).
Secondary endpoints were improvements in nutritional
variables (weight, BMI, and biochemistry), infection occur-
rence (days of antibiotic therapy), and hospitalization.
Statistical Analysis
Data are presented as means  standard deviations. Differ-
ences in proportions were assessed using the chi-square or
Fisher exact test where appropriate. Comparisons of be-
tween-group and within-group quantitative variables were
performed using unpaired and paired, respectively, Student
t-tests. The Mann-Whitney U-test was used for nonhomo-
geneous distribution of variance. Reduction in PUSH score
and PU area from baseline to 12-week follow-up was an-
alyzed using analysis of variance (ANOVA) for repeated
measures (Dunnett test for post hoc comparison of means).
Finally, multiple regression analyses were performed to test,
where possible, the independent contributions of specific
nutrients (protein, arginine, vitamin C, and zinc), energy
intake, and overall formula (independent variables) to ulcer
healing. Such healing (and degree of healing) is defined as
decrease (D) in PUSH score and percentage of reduction in
ulcer area (dependent variables). All statistical analyses
were performed using STATISTIX 7.0 (Analytical Software,
Tallahassee, FL). The level of significance was established as
Po.05.
RESULTS
In total, 371 elderly long-term care residents were screened;
of these, 39 (10.5%) presenting with PUs (Stages II, III, and
IV) were considered eligible for inclusion in the study. Nine
of these were excluded according to the exclusion criteria
(3 with a41-month history of PU, 3 with diabetes mellitus,
2 with terminal neoplastic disease, and 1 with peripheral
vascular disease), leaving 30 patients (77%; 18 women and
12 men) to be randomly allocated to the treatment or con-
trol group. Two patients (both with a single lesion) in the
treatment group died within the first 4 weeks of the follow-
up period (on Days 15 and 22). As a result, the final analysis
sample consisted of 28 participants (13 in the treatment
group and 15 in the control group). Thus, the analyses
cannot be considered intention to treat, although any pos-
sible bias to results may be partly excluded on the grounds
that nutritional intervention can only be considered effec-
tive if it produces a reduction of 20% to 40% in the PU in
the first 4 weeks.28
Demographic and Clinical Features of the Study Sample
The baseline demographic and clinical features of the pop-
ulation and the location and number of ulcers at the differ-
ent sites are presented in Table 1. As shown, no differences
across these variables were detected between groups, and
the location of the ulcers was comparable. Of the
participants recruited, 18 were tube fed (64.3%; 9 in the
treatment group (69.2%) and 9 in the control group (60%);
P5.71, Fisher exact test), and 15 had more than one lesion
(10 in the treatment group (76.9%) and 5 in the control
group (33.3%); P5.03, Fisher exact test).
Biochemical Variables
At baseline, the study groups were well matched for bio-
chemical parameters (Table 2), although at the end of the
study period, the enriched formula nutritional intervention
resulted in significantly higher zinc serum levels (Po.01 vs
baseline). Moreover, after 12 weeks, the control group
showed lower serum zinc levels than the treatment group
(Po.03) and a significant increase in total lymphocyte
count (Po.002 vs baseline).
Food Intake and Adherence to Interventions
Average daily dietary intake data are presented in Table 3.
At baseline, there were no significant differences in total
and weight-normalized (/kg/d) energy, protein, arginine,
zinc, or vitamin C intake. In both groups, the intervention
protocols resulted in a significant increase in energy and all
of the considered nutrients. As expected, allocation to the
treatment protocol was associated with significantly higher
protein (1.5 vs 1.2 g/kg per day), arginine, zinc, and vita-
min C intake (Po.001 for all). Total dietary adherence
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(percentage of food consumed to that delivered) was high
(94.3% control; 94.7% treatment), and oral supplement
consumption was successful. Thus, all patients reached the
85% or greater proposed cutoff. Oral nutritional support
was well accepted, and none of the patients developed any
adverse reaction to the supplements.
Primary Endpoint (PU Healing)
With regard to the trial’s primary endpoint, the provision of
adequate amounts of energy (30 kcal/kg per day) and
protein (1.2 g/kg per day) was effective in improving PU
healing (ANOVA for repeated-measures analysis, Po.001
for both interventions; Figure 1A and B). Table 4 shows the
time-course progression of the healing-process indexes of
both groups. Disease-specific nutritional treatment was as-
sociated with a significantly higher rate of PU healing. The
differences in the interventions became statistically signifi-
cant in PUSH score at Week 12 (Po.05) and in ulcer area
fromWeek 8 (Po.05). Overall, the patients treated with the
enriched formula showed a significantly higher mean re-
duction in PU area (Figure 1C;  57% vs  33% at Week
8, Po.02;  72% vs  45% at Week 12, Po.005). Com-
plete healing was documented for only one patient in the
treatment group. Furthermore, the effect of single nutrients
and that of the overall ‘‘treatment factor’’ on wound healing
were explored. In the overall population, separately ad-
justed (sex, age, and tube feeding) univariate linear regres-
sion models revealed a significant association between a
lower (D) PUSH score (dependent variable) and greater ar-
ginine intake (Dmg/kg per day; coefficient of determination
(R2)5 0.31, Po.05) and the use of a disease-specific for-
mula (R250.37, Po.02), although the grater arginine
(Dmg/kg per day), vitamin C (Dmg/kg per day), and zinc
(Dmg/kg per day) intake, as well as the use of the whole
formula, had a significant effect in reducing the (D%) PU
area (separate models adjusted for sex, age, and tube feed-
ing: R250.42, Po.01; R250.43, Po.01; R250.40,
Po.02; R250.50, Po.01, respectively). Moreover, there
was no significant effect on wound healing (DPUSH and
area) despite the increased energy (Dkcal/kg per day) and
protein (Dg/kg per day) support. Therefore, whether there
remained a significant independent association with single
nutrients was tested also after including the factor ‘‘use of
whole formula’’ (coded as 05 control and 15 treatment) in
models previously showing an association. Only the factor
‘‘use of whole formula’’ was significantly associated
(R20.42, Po.03 in all the analyses), whereas the other
variables did not enter the model.
Secondary Endpoints
With regard to secondary outcome, none of the patients
required hospitalization to treat complications, although
the control group had a slightly higher occurrence of infec-
tious complications (9 subjects vs 3 subjects; P5.07, Fisher
exact test) and a significantly greater number of days of
antibiotic therapy (103 vs 36; Po.001, two-sample pro-
portion test).
DISCUSSION
Malnutrition in elderly populations is associated with poor
clinical outcome and is an indicator of risk not only for
greater mortality, but also for a variety of other complica-
tions.22,23,29 The prevalence of protein-energy malnutrition
in nursing home residents ranges from 23% to 85%, and a
structured approach to its ad hoc management has been
proposed.30 Unfortunately, there is only limited evidence
of the effect of nutritional intervention in preventing PUs.2
Indeed PUs remain a common problem, but early treatment,
including nutrition, might be effective in improving some
wound-healing indices, thus reducing morbidity, mortality,
length of stay, and overall health costs.2,4,5,9 Nutritional
status is a factor that can be influenced positively, and
delivering high-quality nutritional care is an easy process.7
In this scenario, the present RCT clearly suggests that
disease-specific nutritional support is feasible and safe and
in selected cases should be preferred to the standard
Table 1. Baseline Demographic and Clinical Features of
the Population
Variable
Treatment
(n5 13)
Control
(n515)
Male:female 4:9 6:9
Age, mean  SD 82.1  9.6 81.4  9.9
Body mass index, kg/m2,
mean  SD
20.8  3.2 23.1  5.0
Percentage weight loss,
mean  SD
 5.7  5.0  3.6  3.1
Geriatric Nutritional Risk
Index, mean  SD (range)
81.4  11.9
(62.9–101.1)
80.8  9.3
(65.1–96.1)
Norton index, mean  SD
(range)
6.8  1.6 (5–11) 8.7  4.0 (5–17)
Oral feeding:tube feeding 4:9 6:9
Diagnoses, n
Vascular dementia 4 5
Alzheimer’s disease 3 2
Cerebrovascular accident 4 5
Psychiatric disorders 2 2
Multiple sclerosis F 1
Pressure ulcers, n
Stage
II 2 3
III 4 4
IV 7 8
Location
Sacrum 5 8
Back 0 1
Foot 4 3
Ankle 4 3
Number of lesionsw
1 3 10
2 7 2
3 2 3
4 1 0
Statistical comparisons between groups were performed by unpaired Student
t-test, Mann-Whitney U-test (for not Gaussian distribution) or Fisher exact
test (categorical variables).
No significant differences were detected between the treatment and control
groups.
P5 .71, w .03, Fisher exact test.
1398 CEREDA ET AL. AUGUST 2009–VOL. 57, NO. 8 JAGS
approach for improving the rate of PU healing. Unfortu-
nately, there is little literature addressing this issue, andmuch
of the available data are not sufficiently comparableFpop-
ulation and setting heterogeneity, supplement duration vari-
ability, nonhomogeneous healing measurementFto allow
an evaluation of consistent effects.2 Along with this, consid-
eration must also be given to the fact that the only well-
documented evidence for the use of disease-specific nutrition
concerns the use of diabetes-specific formulas in the man-
agement of glycemic control.31
Despite this ‘‘literature lack,’’ recent overviews of
the use of enteral nutrition in PU treatment report a trend
Table 2. Changes in Clinical and Biochemical Parameters Over the Study
Parameter
Mean  Standard Deviation (Range) Mean  Standard Deviation (Range)
Treatment Control
Baseline Week 12 Change Baseline Week 12 Change
Weight gain, kg 53.6  8.8 55.5  9.4 1.8  2.7 64.3  13.6 65.0  12.9 0.7  2.6
Body mass index, kg/m2 20.8  3.2 21.5  3.3 0.7  1.1 23.0  5.0 23.3  4.7 0.3  0.8
Total protein, g/L 63.6  8.4 66.9  6.5 3.3  7.0 63.4  6.7 65.6  4.5 2.2  4.5
Albumin, g/L 29.2  8.5 30.6  5.0 1.4  7.2 27.9  5.6 29.2  4.8 1.3  3.4
Transferrin, mg/dL 171.3  44.1 179.5  57.2 8.2  29.0 161.3  45.7 158.7  33.8  2.6  25.3
Total cholesterol, mg/dL 150.5  40.7 161.2  51.5 10.6  23.6 138.6  30.2 147.1  25.3 8.5  18.5
Hemoglobin, g/L 11.4  1.8 11.6  1.7 0.2  1.5 11.1  1.3 11.2  1.4 0.1  0.7
Lymphocytes/mm3 1,999  898.8 2,017  650 18  647 1,585  500 2,156  615z 571  538
Zinc, mg/dL 346.0  285.5 453.5  267.6w 107.5  106.6 272.9  260.8 240.3  181.6  32.5  87.1
Geriatric Nutritional Risk
Index score
81.4  11.9
(62.9–101.1)
84.2  8.7
(65.0–102.3)
2.8  10.3
( 16.6–17.4)
80.8  9.3
(65.1–96.1)
83.1  7.6
(72.8–102.3)
2.2  5.6
( 4.6–17.2)
Statistical comparisons were performed as follows: unpaired Student t-test or Mann-Whitney U-test (between intervention groups).
Po.03; paired Student t-test (within single intervention group compared with baseline).
Po w .01, z .002.
Table 3. Average Dietary Intake, Both Groups, Throughout the Study
Nutrient
Mean  SD Mean  SD
P-Value
Treatment Group Control Group
Before Study Value Change P-Value Before Study Value Change P-Value
Energy, kcal/d 1,441  262 1,586  211 145  167 .01 1,532  230 1,848  309 316  239 .002 .02
Carbohydrates, % 51.5  3.5 49.0  3.5  2.5  0.8 o.001 51.0  5.3 51.3  4.9 0.3  0.9 .12 .20
Proteins, % 16.1  0.2 19.7  0.9 3.6  0.8 o.001 16.6  2.1 16.4  1.1  0.2  1.1 .64 o.001
Fat
% 32.4  3.5 31.3  3.6  1.1  1.3 .01 32.4  4.9 32.3  4.8  0.1  0.6 .38 .58
kcal/kg per day 27.3  5.5 30.0  4.0 2.7  3.0 .01 24.8  6.6 29.4  4.7 4.6  3.1 o.001 .74
Protein, g/kg per day 1.1  0.2 1.5  0.2 0.4  0.1 o.001 1.0  0.3 1.2  0.2 0.2  0.1 o.001 .001
Arginine 2,004  885 9,822  888 7,818  1,695 o.001 2,322  930 2,888  1,402 566  663 .001 o.001
From protein, mg/d 227  466 566  663
From formula
mg/d 7,590  1,261 F
mg/kg/d 39  22 186.0  22.4 146.5  26.5 o.001 38.3  21 46.0  22.4 7.7  7.6 .002 o.001
Zinc
mg/d 14.1  5.9 26.7  2.4 12.6  4.3 o.001 14.5  5.4 17.5  6.1 3.0  2.2 o.001 o.001
mg/kg per day 0.26  0.10 0.51  0.07 0.24  0.11 o.001 0.23  0.11 0.27  0.08 0.05  0.03 o.001 o.001
Vitamin C
mg/d 127.8  32.3 492.5  69.2 364.7  86.0 o.001 144.0  46.9 201.4  57.9 57.4  66.0 .007 o.001
mg/kg per day 2.4  0.5 9.5  2.7 7.1  2.7 o.001 2.3  0.6 3.2  0.9 0.9  1.1 .007 o.001
Changes are calculated as time point versus baseline; ns5 not significant.
P-values are provided according to statistical analyses using paired Student t-tests (within single study group vs baseline), unpaired Student t-test or Mann-
Whitney U-test (between-group comparison; normal and nonnormal distribution, respectively).
No significant differences in baseline values were detected between the groups.
SD5 standard deviation.
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toward better healing using specific-nutrient supplement-
ation.2,19 Accordingly, the present study has effectively in-
vestigated this issue, particularly with regard to the lack of
energy and protein intake contribution, and revealed that
reaching the target of 30 kcal/kg per day did not seem to
produce any significant effect on wound healing. Moreover,
the controls showed a slightly greater increase in calorie
intake (4.6  3.1 kcal/kg per day) than the treated patients
(2.7  3.0 kcal/kg per day, P5.13). Energy requirements
do not seem to be a critical factor in patients with PUs,15
and the recommendations suggest treating malnutrition us-
ing a nutritional support ranging from 25 to 35 kcal/kg per
day.15,32,33 Similarly, there was no confirmation of the ex-
pected significant effect with regard to protein intake, and
previous studies, which reported a significant anabolic
effect from short-term supplementation of 1.5 g/kg per day
in undernourished elderly subjects,34 suggest improvement
in healing of existing lesions using high-protein-content
(  1.8 g/kg per day) treatments.2,10,16,17 Alternatively, ag-
ing is frequently associated with unbalanced protein turn-
over,35 and increasing intake beyond 1.5 g/kg per day may
not improve nitrogen balance and may cause dehydra-
tion.10,36 Perhaps the supplementation used in the current
trial was not enough to produce an effect on the rate of
healing. It is also possible that the effect of the overall
treatment formula might have masked the healing effect.
Accordingly, it is not possible to provide any practical sug-
gestion for the amount of protein that should be provided in
a nutritional supplement, but in the light of previous ex-
perience with complicated patients13 and in agreement with
recent reassessments in healthy older adults,37 intake of
1.5 g/kg per day might be a positive step. Finally, it cannot
be excluded that reaching a higher intake of calories and
protein would have additionally benefited the rate of
healing.
As anticipated above, these findings support the role of
specific nutrients in the healing process, although the effect
of the overall disease-specific formula seems to predomi-
nate. This is what the multivariate analyses revealed, but
the results should be interpreted cautiously, especially in
view of the small sample size of the study.
Few high-quality clinical trials have investigated the
therapeutic application of nutritional factors. Moreover,
specific nutrients (zinc and vitamin C) have usually been
studied independently, and trials have failed to demonstrate
a significant difference in the rate of healing of patients who
are not deficient, even when supplemented with above-
therapeutic dosages.10 Alternatively, it is well accepted that
vitamin C is essential for wound repair, and zinc might be
implicated in delayed healing, also through impaired im-
mune function.38 Along with this, the administration of the
semi-essential amino acid arginine has shown pleiotropic
effects in healthy older adults (elevation of serum insulin-
like growth factor concentrations and improvement of ni-
trogen balance and immune response and antioxidant pro-
prieties),39,40 but no study in patients with PUs has been
conducted to evaluate its supplementation alone. However,
a recent animal model experience describes better wound
healing with enhanced expression and deposition of extra-
cellular matrix major components (e.g., type I and III col-
lagen).41 Moreover, the significant contribution of an
insulin-related anabolic effect, secondary not only to nu-
tritional repletion, but also to the independent arginine
effect, cannot be excluded.42
Finally, only two RCTs have preliminarily investigated
the efficacy of pooled supplementary arginine, zinc, and
vitamin C.18,19 A short-term (2- or 3-week follow-up)
three-treatment comparison was performed (normal hospi-
tal diet vs high-protein vs high-protein plus additional ar-
ginine, zinc, and antioxidant vitamin), but the improved
rate of healing was reported as inconclusive in the com-
bined-treatment group of both studies. Unfortunately, ma-
jor biases and shortcomings were detected. In the first
trial,18 the data on wound healing, obtained using a ‘‘PU
status tool,’’ were presented only graphically. Moreover, no
information was provided on PU area reduction, dietary
Figure 1. Trend of healing process over the study period: &,
treatment; & , control. (A) Pressure Ulcer Scale for Healing
(PUSH) score: analysis of variance (ANOVA) for repeated mea-
sures, Po.001 in both groups (Dunnett post hoc comparison,
Po.01 from week 6); treatment significantly different from
control at the same time point (Mann-Whitney U-test; Po.02).
(B) Pressure ulcer area: ANOVA for repeated measures, Po.001
in both groups (Dunnett post hoc comparison, Po.01 from
week 6); no statistically significant differences were detected be-
tween groups at any time points. (C) Percentage of decrease in
pressure ulcer area: treatment significantly different from control
at Weeks 8 and 12 (Mann-Whitney U-test; Po.02 and
Po.005, respectively).
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intake and adherence, or inclusion and exclusion criteria
(e.g., history of ulcer, other illnesses). However, another
recent study,19 despite the small set of patients, was well
designed and presented an adequate description of the ex-
clusion and inclusion criteria. Unfortunately, the ulcer sta-
tus of the different treatment groups was monitored only
using the PUSH tool, and unselected biases occurred over
the study period, leading to a significant overestimation of
the healing power of the enriched formula; patients in the
‘‘multiple-supplement’’ group were older and had a lower
baseline BMI and better dietary adherence during the study.
Moreover, there was no information given about oral intake
before the treatment period, and it cannot be excluded that,
in this group, the oral intake was more compromised, thus
enhancing the healing effect of nutritional repletion.
Taken together, these considerations support the con-
sistency of the results of the current study, in which many
limitations have been overcome. Unfortunately, other lim-
itations must be highlighted: the smallness of the sample
and the absence of a control group supplemented only with
protein. Only elderly institutionalized people with a recent
history of PUs were included, so it was not possible to ex-
tend the use of the disease-specific formula to all of the PU
patients. Moreover, the orally and tube-fed subjects were
analyzed together, and this choice might have strengthened
the results through the effect of better adherence to treat-
ment; subjects undergoing oral nutritional support fre-
quently consume supplements at the expense of other
food,43 but providing the results of subgroup analyses
would have been of little statistical significance. With re-
gard to statistics, no intention-to-treat analysis was per-
formed, in accordance with the exclusion of dead patients
from the treatment group, although it appears that at least 4
weeks of follow-up is required to appreciate the effective-
ness of nutritional intervention in the healing of PUs.28
Finally, it is also possible that the difference found in ulcer
healing was partly due to a mild impairment of immuno-
competence, as described according to total lymphocyte
count, a parameter considered to contribute significantly to
lesion development,10,12,44 even though no significant effect
was detected using ad hoc linear regression analysis (data
not shown in Results section). Along with this, immune
function might have negatively influenced the occurrence of
infection in the control group, although the well-known
positive effect of nutritional repletion and micronutrient
status45,46 on immune response might support an immune-
enhancing effect of the enriched formula. In conclusion, in
patients affected by PUs, the use of disease-specific nutri-
tional support should be considered, at least in elderly res-
idents of long-term care with a recent history of PUs. This
not only would probably allow shorter healing times, but
would also reduce the overall costs of PU care. Further high-
quality studies (RCTs) are needed to confirm these prelim-
inary results, which have opened a new field of research.
In view of this, the application of disease-specific nutritional
protocols and study design should involve major items such
as the setting in which PUs occur (hospital–acute care, sub-
acute care, long-term care, home care), the age of the re-
cruited population (young, middle aged, elderly), the history
of ulcers (recent onset, chronic disease) and concomitant
diseases. Moreover, a pharmacoeconomic evaluation should
also be considered to evaluate the cost-effectiveness of using
disease-specific formulas.
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